🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Just issued: Rapid guideline update on endocrine and targeted therapy for HR-positive, HER2-negative metastatic #BreastCancer - capivasertib-fulvestrant. Read more: brnw.ch/21wHQVC #bcsm #mBC

I am in awe of Mass General Cancer Center MGH Women in Oncology Aparna Raj Parikh running her first marathon to raise funds for ColinsJoyProject to enhance children/family program in S Boston. The McGrath family inspires us all boston.com/community/bost…

Excellent presentation at AACR by Rachel Occhiogrosso Abelman, MD on TOP1 mutations mediating cross-resistance to ADCs. Implications for ADC sequencing and drug development in MBC. #bcsm

I can't think of a better person to advise ASCO about early career and trainee issues. Congratulations! MGH Women in Oncology MGH Breast Oncology Mass General Cancer Center

Do you know of any children dealing with any form of #cancer? We’re chatting with an awesome young man with an inspiring story about his journey. Join us Sunday evening at 7:00 PM. Joseph Betancourt Rick Lee 이재방 Beverly Moy Kevin M. Simon, MD, MPH Bisola Ojikutu MD MPH FIDSA

I’m pleased to help organize with James ‘Jimmy’ Hills the THIRD Your Healthy Java / Joseph R Betancourt Health Fair in Roxbury, Boston, MA. We are bringing cancer specialists and information to the community on Saturday, May 11, 2024. Please join us!

Saturday’s #YourHealthyJava Joseph R. Betancourt Health Fair is made possible J&J Innovative Medicine & Bayer U.S. 🇺🇸 & The New Commonwealth Fund Thank you to our sponsors. Join us... jwj.info/healthfair24! Also thanks to Rick Lee 이재방 for picking up the mantle from Joseph Betancourt supporting #healthequity

Amazing to celebrate the brilliant Conquer Cancer Foundation grant awardees, especially proud of ⁦⁦Rachel Occhiogrosso Abelman, MD⁩ Ellis, Leon Pappas YIA winners and Catherine Meador CDA winner of ⁦Mass General Cancer Center⁩ #ASCO24

Goals of care conversations should happen early and throughout the disease trajectory. ⁦Mass General Cancer Center⁩ ⁦MGH Women in Oncology⁩ ⁦MGH Breast Oncology⁩ Dr. Jenn Shin takes us through how to respond, understand, respect, support, and explore in these conversations.

Keeping the ASCO lung cancer guidelines current is no small feat! Thank you, panel members and ASCO staff. #ASCO24

⁦Kevin Kalinsky, MD, MS, FASCO⁩ presents postMONARCH, the first trial showing benefit of continuing CDK4/6 inhibition after progression on prior CDK. Congrats to investigators, including senior author ⁦Mass General Cancer Center⁩ ⁦MGH Breast Oncology⁩ Seth Wander #ASCO24

Triple combo of inavolisib plus palbo plus fulvestrant meaningfully improves PFS and more in first line met ER+ PIK3CA mutant breast cancer. This is a very promising treatment. Amazing work energetically presented by ⁦Mass General Cancer Center⁩ Dejan Juric and colleagues #ASCO24

Amazing discussion with Lori Pierce and ⁦Dr. Rob Winn⁩ at #ASCO24 EDI breakfast. “We have to do what is possible.” How we respond to challenges is vital. Missing 3 giants: Worta McCaskill-Stevens, Bill Blackstock, and Edith Mitchell.

Dynamic duo of ⁦Mass General Cancer Center⁩ ⁦MGH Women in Oncology⁩ ⁦MGH Breast Oncology⁩ ⁦Rachel Occhiogrosso Abelman, MD⁩ and Neelima Vidula presenting breast posters side by side on SG plus PARPi and immune related adverse events

I’m honored and thrilled to chair the brilliant ⁦ASCO⁩ Evidence Based Medicine Committee charged to provide the highest quality clinical practice #ASCOGuidelines. An impressive group of volunteer experts and staff! Lotsa guidelines coming your way!

We’ve issued a rapid guideline update for the management of stage III #NSCLC. ➡️ brnw.ch/21wKCWv #lungcancer #lcsm

We’ve issued a rapid guideline update on systemic therapy for #sclc. These recommendations are considered provisional pending full text review of publication and confirmation of data. ➡️ brnw.ch/21wKD3i #lungcancer #lcsm

Such warm hospitality from Indonesian oncologists! Representing #ASCOGuidelines @asco at their annual oncology meeting, ISMI HOTTI. Jakarta is the kota kolaborasi, or city of collaboration, indeed! Thanks Beverly Moy Christina Annunziata Nancy Baxter MD PhD for joining virtually! Thanks for having

I am thrilled to support Mass General Cancer Center MGH Women in Oncology team! Please donate or join us on Sep 15th to see if the rumors that I am singing with Jeffrey peppercorn MD band "What She Said" are true. because.massgeneral.org/fundraiser/572…

The US FDA has approved adjuvant ribociclib + AI for HR+ HER2- Stage II and III breast cancer pts. Let's put our heads together to better explore appropriate use, given pt financial burden, ~8% grade 3 transaminase rate, and other toxicity. Choice of CDK 4/6 inhibitor? Duration?